These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 9117036
1. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection. Shreve MR, Johnson SJ, Milla CE, Wielinski CL, Regelmann WE. Am J Respir Crit Care Med; 1997 Mar; 155(3):984-9. PubMed ID: 9117036 [Abstract] [Full Text] [Related]
2. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, Santino I, Stefani S, Sessa R, Nicoletti M. Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935 [Abstract] [Full Text] [Related]
3. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. McDowell A, Mahenthiralingam E, Moore JE, Dunbar KE, Webb AK, Dodd ME, Martin SL, Millar BC, Scott CJ, Crowe M, Elborn JS. J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828 [Abstract] [Full Text] [Related]
4. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. Ryley HC, Millar-Jones L, Paull A, Weeks J. J Med Microbiol; 1995 Dec; 43(6):436-41. PubMed ID: 7473677 [Abstract] [Full Text] [Related]
5. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H, Vandamme P, Van Zeebroeck A, De Boeck K, Struelens MJ, Verhaegen J, Ursi JP, Verschraegen G, Franckx H, Malfroot A, Dab I, Lauwers S. Acta Clin Belg; 1996 Dec; 51(4):222-30. PubMed ID: 8858887 [Abstract] [Full Text] [Related]
6. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Minicucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A. J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994 [Abstract] [Full Text] [Related]
7. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroecke K, Gillis M, Speert DP, Vandamme P. Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071 [Abstract] [Full Text] [Related]
9. Usefulness of Sau-PCR for molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia which occurred in a local hospital in Guangzhou, China. Yan H, Shi L, Alam MJ, Li L, Yang L, Yamasaki S. Microbiol Immunol; 2008 May; 52(5):283-6. PubMed ID: 18557899 [Abstract] [Full Text] [Related]
10. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429 [Abstract] [Full Text] [Related]
11. Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland. Crowley D, Daly M, Lucey B, Shine P, Collins JJ, Cryan B, Moore JE, Murphy P, Buckley G, Fanning S. J Appl Microbiol; 2002 Mar; 92(5):992-1004. PubMed ID: 11972706 [Abstract] [Full Text] [Related]
12. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM. J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938 [Abstract] [Full Text] [Related]
14. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. Agodi A, Mahenthiralingam E, Barchitta M, Gianninò V, Sciacca A, Stefani S. J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009 [Abstract] [Full Text] [Related]
15. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, Johnson JA, LiPuma JJ. Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209 [Abstract] [Full Text] [Related]
16. An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, Steinbach S, Goldstein R. J Infect Dis; 1999 May; 179(5):1197-205. PubMed ID: 10191223 [Abstract] [Full Text] [Related]
18. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, Davidson AG, Wilcox PG, Nakielna B, Speert DP. Clin Infect Dis; 2001 Nov 01; 33(9):1469-75. PubMed ID: 11588691 [Abstract] [Full Text] [Related]
19. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Karpati F, Jonasson J. Mol Cell Probes; 1996 Dec 01; 10(6):397-403. PubMed ID: 9025076 [Abstract] [Full Text] [Related]
20. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran. Dallal MM, Telefian CF, Hajia M, Kalantar E, Dehkharghani AR, Forushani AR, Khanbabaei Q, Mobarhan M, Farzami MR. J Prev Med Hyg; 2014 Mar 01; 55(1):27-30. PubMed ID: 25916029 [Abstract] [Full Text] [Related] Page: [Next] [New Search]